TjakTjak SRL
TjakTjak reported total assets of 71,688 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026).
The score of TjakTjak shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +65 % Total assets +38 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
TjakTjak's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 21 Jun 2024
TjakTjak's financial analysis
- Solvency97.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of TjakTjak
TjakTjak's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.166.903
- VAT number
- BE0795166903
- Peppol
- Registered · 0208:0795166903 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Dec 2022
- Registered office
- 3500 Hasselt
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
TjakTjak (SRL) has been based in Hasselt since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 18,821 € and equity of 69,724 €; its revenue is not published. Its solvency stands at 97.3%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to TjakTjak
Companies in the same business, of comparable size and area, outside its group.
- Buma Pharma Retail sale of pharmaceutical products Antwerp · balance sheet 57,247 €
- MBV Consult Retail sale of pharmaceutical products Lier · balance sheet 63,750 €
- Vangheluwe L. Retail sale of pharmaceutical products Ninove · balance sheet 65,040 €
- Sander Koyen Retail sale of pharmaceutical products Wuustwezel · balance sheet 82,286 €
- Woodpecker Invest Retail sale of pharmaceutical products Aalter · balance sheet 162,763 €
- SoBayFRo Retail sale of pharmaceutical products Tournai · balance sheet 54,756 €
- Neopharm Retail sale of pharmaceutical products Jette · balance sheet 94,350 €
- IBCM Pharma Retail sale of pharmaceutical products Lasne · balance sheet 100,830 €
Frequently asked questions about TjakTjak
What is the revenue of TjakTjak?
TjakTjak files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of TjakTjak?
In Belgium, the VAT number is the company number prefixed with BE: BE0795166903 for TjakTjak, if the company is VAT-registered. Its company number (CBE) is 0795.166.903.
Where is the registered office of TjakTjak?
According to the CBE register, the registered office of TjakTjak is in 3500 Hasselt.
What is the equity of TjakTjak?
At the close of the 2025 financial year, the equity of TjakTjak amounts to 69,724 €, a solvency of 97.3% of total assets.
Who manages TjakTjak?
The register lists 1 active mandates at TjakTjak. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of TjakTjak
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →